Cerebral infarction 3 weeks after intravenous immunoglobulin for Miller Fisher syndrome: a case report
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1752-1947
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Cerebral infarction 3 weeks after intravenous immunoglobulin for Miller Fisher syndrome: a case report ; volume:8 ; number:1 ; day:24 ; month:3 ; year:2014 ; pages:1-3 ; date:12.2014
Journal of medical case reports ; 8, Heft 1 (24.3.2014), 1-3, 12.2014
- Creator
-
Chang, Thashi
- Contributor
-
de Alwis, Johann Shenoj
Samarasekara, Neirosha
Rajapakse, Senaka
SpringerLink (Online service)
- DOI
-
10.1186/1752-1947-8-100
- URN
-
urn:nbn:de:1111-201607115712
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Chang, Thashi
- de Alwis, Johann Shenoj
- Samarasekara, Neirosha
- Rajapakse, Senaka
- SpringerLink (Online service)
Other Objects (12)
Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy
Intravenous immunoglobulin G therapy for neonatal hyperbilirubinemia
Intravenous immunoglobulin therapy in COVID-19-related encephalopathy
Treatment of multiple system atrophy using intravenous immunoglobulin
Intravenous immunoglobulin treatment in a patient with adrenomyeloneuropathy
Periorbital Necrobiotic Xanthogranuloma Successfully Treated with Intravenous Immunoglobulin
Neonatal Hemochromatosis: Treatment with Exchange Transfusion and Intravenous Immunoglobulin
Antifungal antibodies present in intravenous immunoglobulin derived from China
Intravenous immunoglobulin and Alzheimer’s disease: what now?
Hemolytic anemia associated with intravenous immunoglobulin in Kawasaki disease
Potential therapeutic approach of intravenous immunoglobulin against COVID-19
Alternatives to intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy
Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy
Intravenous immunoglobulin G therapy for neonatal hyperbilirubinemia
Intravenous immunoglobulin therapy in COVID-19-related encephalopathy
Treatment of multiple system atrophy using intravenous immunoglobulin
Intravenous immunoglobulin treatment in a patient with adrenomyeloneuropathy
Periorbital Necrobiotic Xanthogranuloma Successfully Treated with Intravenous Immunoglobulin
Neonatal Hemochromatosis: Treatment with Exchange Transfusion and Intravenous Immunoglobulin
Antifungal antibodies present in intravenous immunoglobulin derived from China
Intravenous immunoglobulin and Alzheimer’s disease: what now?
Hemolytic anemia associated with intravenous immunoglobulin in Kawasaki disease
Potential therapeutic approach of intravenous immunoglobulin against COVID-19
Alternatives to intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy
Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy
Intravenous immunoglobulin G therapy for neonatal hyperbilirubinemia
Intravenous immunoglobulin therapy in COVID-19-related encephalopathy
Treatment of multiple system atrophy using intravenous immunoglobulin
Intravenous immunoglobulin treatment in a patient with adrenomyeloneuropathy
Periorbital Necrobiotic Xanthogranuloma Successfully Treated with Intravenous Immunoglobulin
Neonatal Hemochromatosis: Treatment with Exchange Transfusion and Intravenous Immunoglobulin
Antifungal antibodies present in intravenous immunoglobulin derived from China
Intravenous immunoglobulin and Alzheimer’s disease: what now?
Hemolytic anemia associated with intravenous immunoglobulin in Kawasaki disease
Potential therapeutic approach of intravenous immunoglobulin against COVID-19